Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma
Clinical trial NCT02432235 · COMPLETED
Trial details
- NCT number
- NCT02432235
- Sponsor
- ADC Therapeutics S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-05
- Primary completion
- 2019-10-24
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.